You are here

Allergan

Got Lolo? Allergan hypes ultralow-estrogen birth control in first major brand push

Fierce Pharma

Mon, 07/30/18 - 11:04 pm

DTC advertising

birth control pill

Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan

Yahoo/Zacks.com

Thu, 07/26/18 - 12:08 pm

Allergan’s eye contender cannot knock Eylea off its perch

EP Vantage

Sun, 07/22/18 - 12:24 pm

wet age-related macular degeneration

Federal judges ban Allergan’s sovereign immunity scheme in a slapdown that will bolster inter partes review for years to come

Endpoints

Sat, 07/21/18 - 02:03 pm

inter partes review

Could synthetic Botox soothe chronic pain? A new study holds out the possibility

Stat

Wed, 07/18/18 - 10:53 pm

Ironwood Initiates Ph III Study of Linaclotide in IBS-C

CP Wire

Mon, 07/16/18 - 09:08 am

Ironwood Pharmaceuticals

Ironwood Initiates Ph III Study of Linaclotide in IBS-C

Mon, 07/16/18 - 09:06 am

Ironwood Pharmaceuticals

Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug

Endpoints

Thu, 07/12/18 - 11:49 am

dry eye disease

Celgene pledges to limit price hikes—or does it?

Fierce Pharma

Wed, 07/4/18 - 10:10 am

Allergan: This $64,000 Question Could Kill Restasis IPR Appeal

NY Shock Exchange

Thu, 06/28/18 - 09:28 am

What's next for embattled Allergan? Depends on pipeline performance, analysts say

Fierce Pharma

Tue, 06/19/18 - 10:57 am

Allergan (AGN) Presents Positive Data on Glaucoma Candidate

Yahoo/Zacks.com

Thu, 06/14/18 - 10:24 pm

Open-Angle Glaucoma

ocular hypertension

Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions

NY Shock Exchange

Thu, 06/14/18 - 06:48 pm

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Fierce Pharma

Mon, 06/11/18 - 05:17 pm

Allergan's Migraine Prevention Drug Meets Primary Endpoints in Ph Iib/III Study

CP Wire

Mon, 06/11/18 - 09:15 am

Notorious activist investor Carl Icahn buys small stake in Allergan

Endpoints

Thu, 06/7/18 - 09:37 am

Allergan's tribal licensing deal, opposed by tech giants, gets appeals court scrutiny

Fierce Pharma

Tue, 06/5/18 - 10:44 pm

How Allergan went from a tiny but beloved Southern California eye care company to a dealmaking machine to falling out of grace with investors (AGN)

Business Insider

Sun, 06/3/18 - 10:22 am

FDA stalls yet another Herceptin copycat, issuing response letter to Amgen/Allergan

Endpoints

Fri, 06/1/18 - 10:40 pm

complete response letter

Allergan plans sales of women's health, infectious disease units

Reuters

Wed, 05/30/18 - 11:57 am

infectious diseases

Pages